ALK POSITIVE
Clinical trials for ALK POSITIVE explained in plain language.
Never miss a new study
Get alerted when new ALK POSITIVE trials appear
Sign up with your email to follow new studies for ALK POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted pill may keep ALK lung cancer from returning after surgery
Disease control OngoingThis study tests whether taking crizotinib after surgery can help people with early-stage ALK-positive non-small cell lung cancer live longer and keep the cancer from coming back. About 166 participants who had their tumor removed will either receive crizotinib pills or be watche…
Matched conditions: ALK POSITIVE
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Apr 29, 2026 02:38 UTC
-
New drug cocktail targets Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests the safety and best dose of two drugs, ceritinib and everolimus, given together to adults with advanced solid tumors or a type of lung cancer called ALK-positive NSCLC. The goal is to see if the combination can stop tumor growth by blocking key enzyme…
Matched conditions: ALK POSITIVE
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 02:37 UTC